David Gómez-Almaguer
Universidad Autónoma de Nuevo León
401 Papers
1.3K Citations
David Gómez-Almaguer is an academic researcher from Universidad Autónoma de Nuevo León. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 30, co-authored 309 publications.
Chat about Author
Papers
Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
TL;DR: The diminished expression of the glycolsylphosphatidylinositol-anchored type I cell surface proteins CD55 and CD59 is not specific to PNH and that it can be found in patients with a variety of autoimmune disorders.
Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia.
Claudia Maribel Luna-Aguirre,Margarita L Martinez-Fierro,Fermín Mar-Aguilar,Idalia Garza-Veloz,Víctor Treviño-Alvarado,Augusto Rojas-Martinez,José Carlos Jaime-Pérez,Guadalupe Ismael Malagon-Santiago,César Homero Gutiérrez-Aguirre,Oscar González-Llano,Rosario Salazar-Riojas,Alfredo Hidalgo-Miranda,Herminia G. Martínez-Rodríguez,David Gómez-Almaguer,Rocio Ortiz-Lopez +14 more
TL;DR: Measuring circulating levels of specific miRNA implicated in regulation of cell differentiation and/or cell proliferation such as hsa-miRNA-511, offers high sensitivity and specificity in B-ALL detection and may be potentially useful for detection of disease progression, as indicator of therapeutic response, and in the assessment of biological and/ or therapeutic targets for patients with B-all.
CRLF2 Expression in Mexicans with Acute Lymphoblastic Leukemia across the Age Spectrum
Héctor A. Martínez-Espinosa,Nereida Méndez-Ramírez,Julia E. Colunga-Pedraza,E. Fuentes-Chávez,R. Salazar‐Riojas,Odra Martínez-González,Antonio Vega-Mateos,Oscar Gonzalez Llano,Ingrid López-Reyna,David Gómez-Almaguer,Andrés Gómez-De León,Vanessa Treviño-Sordia,Roberto Solano-Texta +12 more
TL;DR: The significance of CRLF2 overexpression as a cost-effective biomarker indicative of an unfavorable prognosis in ALL across the age spectrum is highlighted and underscores the importance of conducting population-specific research to gain comprehensive insights into the genetic landscape and disease characteristics of ALL in different ethnic groups.
Capizzi Vs HDMTX in the Intermediate Maintenance Phase in Patients with Intermediate-Risk ALL in a 3rd Level Hospital in Northeastern Mexico
Valeria Fuentes,Yajaira Valentine Jimenez-Antolinez,Ginna Mariana Romero-Jacobo,Paulina Garcia - Maldonado,J. P. Ruiz-Padilla,Samantha Carolina Rodriguez- Miranda,J. Marcos-Garcia,Julia E. Colunga-Pedraza,David Gómez-Almaguer,Oscar Gonzalez Llano +9 more
TL;DR: A feasible, economical and accessible ambulatory scheme, which may represent an option for those centers that do not have the infrastructure for maintenance with HDMTX in the intermediate maintenance phase of patients diagnosed with intermediate-risk B- ALL is explored.
Altered CSF cytokine network in amyotrophic lateral sclerosis patients: A pathway-based statistical analysis
Héctor R. Martínez,Héctor R. Martínez,César E. Escamilla-Ocañas,Juan Miguel Tenorio-Pedraza,David Gómez-Almaguer,José Carlos Jaime-Pérez,Leticia A. Olguín-Ramírez,Leticia A. Olguín-Ramírez,Sergio Salazar-Marioni,María Teresa González-Garza +9 more
TL;DR: Cytokine‐network changes and the positive correlation between IL4 and IL6 were related to disease length; these variations might explain the deleterious immunological effects on motor neurons.